Ubs Asset Management Americas Inc Agios Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 113,229 shares of AGIO stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,229
Previous 125,470
9.76%
Holding current value
$3.89 Million
Previous $5.41 Million
7.02%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$195 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$191 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$167 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$128 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$97.4 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.88B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...